iPierian's Grant - II Round

iPierian raised a round of funding on May 18, 2010. Investors include California Institute of Regenerative Medicine.

iPierian is a biotechnology company developing therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau protein for treatment of Al…

Articles about iPierian's Grant - II Round: